학술논문
In Vitro Evidence of Double Blockade of Asciminib with Reduced Dose of ATP-Binding Pocket Inhibitors in the Treatment of Chronic Myeloid Leukemia Harboring ABL1 Kinase Domain Mutation
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:9588-9589
Subject
Language
ISSN
0006-4971